START- Los Angeles

Los Angeles, California 90025

13 studies enrolling now · 13 studies all time

What they study most

Advanced Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors, Breast Cancer, Castration-Resistant Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma, EGFR, Endometrial Cancer, Epidermal Growth Factor

Studies at this site

• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer — Recruiting now
• A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. — Recruiting now
• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer — Recruiting now
• Study of Oral MRT-2359 With Apalutamide in Prostate Cancer — Recruiting now
• A Study in Patients With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
• A Study of IDP-001 in Advanced or Metastatic Solid Tumors — Recruiting now
• A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors — Recruiting now
• Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors — Recruiting now
• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — Recruiting now
• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — Recruiting now
• Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer — Recruiting now
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors — Recruiting now
• Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy — Starting soon